Regeneron Pharmaceuticals, Inc.

BVL:REGN Stock Report

Market Cap: US$90.5b

Regeneron Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BVL:REGN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 Aug 24SellUS$6,363,588Christopher FenimoreIndividual5,280US$1,206.30
28 Aug 24SellUS$482,674Christopher FenimoreIndividual400US$1,206.70
08 Aug 24SellUS$5,636,346Neil StahlIndividual5,197US$1,086.15
26 Feb 24SellUS$990,000Joseph LaRosaIndividual1,000US$990.00
22 Feb 24SellUS$967,650Joseph LaRosaIndividual1,000US$967.65
14 Feb 24SellUS$9,831,727Daniel Van PlewIndividual10,434US$951.77
09 Feb 24SellUS$4,689,320Christopher FenimoreIndividual4,919US$955.00
07 Feb 24SellUS$7,637,954Neil StahlIndividual8,037US$953.00
07 Feb 24SellUS$950,000Joseph LaRosaIndividual1,000US$950.00
05 Feb 24SellUS$934,710Marion McCourtIndividual1,000US$934.71

Insider Trading Volume

Insider Buying: REGN insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of REGN?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2700.00025%
State or Government123,6310.115%
Individual Insiders4,314,8824%
General Public7,083,6216.56%
Institutions96,412,12589.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 65.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.54%
FMR LLC
10,294,536US$8.6b-1.54%0.56%
8.33%
The Vanguard Group, Inc.
8,993,970US$7.5b0.71%0.12%
7.95%
Capital Research and Management Company
8,582,393US$7.2b1.95%0.37%
7.83%
BlackRock, Inc.
8,446,366US$7.1b-1.43%0.12%
6.62%
JP Morgan Asset Management
7,146,864US$6.0b5.55%0.73%
4.49%
State Street Global Advisors, Inc.
4,841,127US$4.1b-0.01%0.17%
2.24%
Geode Capital Management, LLC
2,415,350US$2.0b1.63%0.16%
2.22%
Leonard Schleifer
2,395,911US$2.0b-1.07%no data
2.15%
Dodge & Cox
2,315,686US$1.9b-1.87%0.68%
1.36%
Putnam LLC
1,466,264US$1.2b18.9%1.28%
1.13%
Loomis Sayles & Company, L.P.
1,216,856US$1.0b0.8%1.44%
1.07%
George Yancopoulos
1,153,695US$967.0m-11.9%no data
1.04%
Norges Bank Investment Management
1,126,948US$944.6m6.14%0.08%
1.02%
UBS Asset Management AG
1,102,143US$923.8m17%0.11%
0.99%
Amundi Asset Management SAS
1,066,449US$893.9m0.12%0.2%
0.98%
Wellington Management Group LLP
1,061,791US$890.0m-2.85%0.15%
0.91%
Legal & General Investment Management Limited
978,109US$819.9m0.02%0.16%
0.9%
Northern Trust Global Investments
966,726US$810.3m-2.5%0.13%
0.86%
T. Rowe Price Group, Inc.
932,874US$781.9m3.35%0.07%
0.79%
BNY Asset Management
856,075US$717.6m-2.58%0.14%
0.77%
American Century Investment Management Inc
825,832US$692.2m-6.36%0.37%
0.75%
Morgan Stanley, Investment Banking and Brokerage Investments
809,335US$678.4m-0.15%0.09%
0.7%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
760,563US$637.5m9.54%0.18%
0.64%
AllianceBernstein L.P.
695,097US$582.6m-5.63%0.19%
0.61%
Charles Schwab Investment Management, Inc.
661,762US$554.7m0%0.1%